Drug Trial Radar · NCT04667377
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
Last checked: Nov 19, 2026Latest source record: Nov 2, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
387
Actual
Start
Mar 8, 2021
Primary completion
Sep 15, 2022
Study completion Oct 7, 2022
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Dec 14, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to adults, aged 18 to 75 years, with overweight or obesity. People with body mass index (BMI) of 27 or higher to join the study. People who have diabetes cannot participate. The purpose of this study is to find out whether a medicine called BI 456906 helps people lose weight. Participants are put into 5 groups by chance. 4 groups get different doses of BI 456906. The fifth group gets placebo. Participants get BI 456906 or placebo as injections under the skin once a week. Placebo injections look like BI 456906 injections but do not contain any medicine. Participants are in the study for about a year. During this time, there are about 20 in-person visits to the study site. At the study site visits, doctors measure participants' body weight. Results are compared between the BI 456906 groups and the placebo group. The doctors also regularly check the general health of the participants.
Conditions
- Obesity
Interventions
BI 456906Drug
BI 456906
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage Change in Body Weight From Baseline to Week 46Time frame: Baseline, Week 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 24, 28, 32, 36, 40, and 46.
Locations
43 sites in 12 countries. Site status is shown where the registry gives one.
Diablo Clinical Research
Walnut Creek, California
L-MARC Research Center
Louisville, Kentucky
Lucas Research, Inc.
Morehead City, North Carolina
PMG Research of Wilmington, LLC
Wilmington, North Carolina
Valley Weight Loss Clinic
Fargo, North Dakota
Velocity Clinical Research, Inc.
Cleveland, Ohio
TLM Medical Services, LLC
Columbia, South Carolina
Coastal Carolina Research Center
North Charleston, South Carolina
Washington Center for Weight Management and Research, Inc.
Arlington, Virginia
Allegiance Research Specialists
Wauwatosa, Wisconsin
The Boden Initiative
Camperdown, New South Wales, Australia
Nepean Hospital
Kingswood, New South Wales, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Eastern Clinical Research Unit
East Ringwood, Victoria, Australia
Austin Health
Heidelberg, Victoria, Australia
UZ Leuven
Leuven, Belgium
Joanne F Liutkus Medicine Professional Corporation
Cambridge, Ontario, Canada
Bluewater Clinical Research
Sarnia, Ontario, Canada
Canadian Phase Onward Inc.
Toronto, Ontario, Canada
LMC Clinical Research Inc. (Bayview)
Toronto, Ontario, Canada
Recherche GCP Research
Montreal, Quebec, Canada
Beijing Chao-Yang Hospital
Beijing, China
Beijing Luhe Hospital Capital Medical University
Beijing, China
The First Hospital of Jilin University
Changchun, China
Wuhan Union Hospital
Wuhan, China
Klinische Forschung Berlin GbR
Berlin, Germany
Universitätsklinikum Carl Gustav Carus Dresden
Dresden, Germany
EB Flevoresearch
Almere Stad, Netherlands
PT & R
Beek, Netherlands
Franciscus Gasthuis
Rotterdam, Netherlands
Albert SchweitzerZiekenhuis
Zwijndrecht, Netherlands
Optimal Clinical Trials
Auckland, New Zealand
P3 Research
Newtown Wellington NZ, New Zealand
Salvia Lekston I Madej Sp. J.
Katowice, Poland
Metabolic Health Center Pawel Bogdanski
Poznan, Poland
Seoul National University Bundang Hospital
Seongnam, South Korea
Kyung Hee University Hospital at Gangdong
Seoul, South Korea
The Catholic University of Korea, Yeouido St.Mary's Hospital
Seoul, South Korea
Ladulaas Kliniska Studier
Borås, Sweden
Forskningsenheten Carlanderska
Gothenburg, Sweden
Showing 40 of 43 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.